Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-12

FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved Padagis Israel Pharmaceuticals Ltd's original application for a calcipotriene and betamethasone dipropionate topical product, a generic combination…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene and Betamethasone Dipropionate (Calcipotriene and Betamethasone Dipropionate)

Snippet

ORIG AP for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE (CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE)